Brief: Acumen Pharmaceuticals Says As Of June 30, 2023, Cash And Cash Equivalents And Marketable Securities Were About $172.2 Mln
17/07/2023 22:05
July 18 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O :
* ACUMEN PHARMACEUTICALS - AS OF JUNE 30, 2023, CASH AND
CASH
EQUIVALENTS AND MARKETABLE SECURITIES WERE ABOUT $172.2 MILLION
* ACUMEN PHARMACEUTICALS INC- EXPECTS TO FILE PRELIMINARY
PROSPECTUS SUPPLEMENT WITH SEC IN CONNECTION WITH PROPOSED
OFFERING OF SHARES OF COMMON STOCK
Further company coverage: ABOS.O
(Reuters.Briefs@thomsonreuters.com)